BIO CEO & Investor Conference
10 February 202511 February 2025
New York, USAThe New York Marriott Marquis
One of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies.
The Conference is presented by BIO, a non-profit policy and advocacy organization for the biotechnology industry.
Each year the BIO CEO & Investor Conference provides a forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry, financing promising discoveries to results in better patient outcomes.
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze